Compounds > haloperidol

haloperidol and sb 334867-a

haloperidol has been researched along with sb 334867-a in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, S; Khotib, J; Miyatake, M; Nagumo, Y; Nakamachi, T; Narita, M; Sakurai, T; Shioda, S; Suzuki, T; Yanagisawa, M1
Hsu, MA; Rasmussen, K; Yang, Y1
Hemrick-Luecke, SK; Hsu, MA; Johnson, BG; Noone, S; Rasmussen, K; Thompson, LK1
De Carolis, L; Milella, MS; Nativio, P; Nencini, P; Passarelli, F; Scaccianoce, S; Schepisi, C1
Chen, AQ; Chen, H; Chen, L; Chen, WF; Chen, XY; Liu, HX; Liu, HY; Pang, YY; Sheng, Q; Wang, Y; Xue, Y; Yang, YT1

Other Studies

5 other study(ies) available for haloperidol and sb 334867-a

ArticleYear
Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Jan-11, Volume: 26, Issue:2

    Topics: Animals; Benzoxazoles; Conditioning, Operant; Desipramine; Dopamine; Female; Haloperidol; Injections, Intraventricular; Injections, Subcutaneous; Intracellular Signaling Peptides and Proteins; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Microdialysis; Microinjections; Morphine; Motor Activity; Naphthyridines; Neuropeptides; Nucleus Accumbens; Orexins; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reward; RNA, Messenger; Tyrosine 3-Monooxygenase; Urea; Ventral Tegmental Area

2006
The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:4

    Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Benzoxazoles; Brain; Dopamine; Drug Interactions; Haloperidol; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neurons; Neuropeptides; Olanzapine; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Time Factors; Urea

2007
The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms.
    Schizophrenia bulletin, 2007, Volume: 33, Issue:6

    Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Benzodiazepines; Benzoxazoles; Catalepsy; Haloperidol; Intracellular Signaling Peptides and Proteins; Locomotion; Male; Naphthyridines; Neuropeptides; Olanzapine; Orexins; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Urea

2007
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia.
    Psychopharmacology, 2010, Volume: 211, Issue:3

    Topics: Animals; Benzoxazoles; Cerebral Cortex; Conditioning, Operant; Corticosterone; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking; Drug Synergism; Haloperidol; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neuropeptides; Orexins; Psychotic Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Urea

2010
Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.
    The European journal of neuroscience, 2016, Volume: 44, Issue:5

    Topics: Action Potentials; Animals; Benzoxazoles; Globus Pallidus; Haloperidol; Male; Naphthyridines; Neurons; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Oxidopamine; Parkinson Disease; Postural Balance; Rats; Rats, Wistar; Urea

2016